Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ARDX — Ardelyx, Inc.

CIK 861177 NEW YORK, NY
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,480,698
-$158,936 QoQ
Shares Held
486,412
+10.4% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 250 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 49% Shared 0% None 51%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. ARDX ranks #93 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in ARDX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,480,698 486,412
2026-03-31 $2,639,634 440,674
2025-12-31 $2,514,167 431,247
2025-09-30 $2,039,297 370,109
2025-06-30 $2,486,236 634,245
2025-03-31 $2,567,185 522,849
2024-12-31 $2,931,753 578,256
2024-09-30 $3,003,775 435,962
2024-06-30 $3,552,395 479,406
2024-03-31 $2,256,406 309,097
2023-12-31 $1,926,004 310,646
2023-09-30 $1,275,483 312,619
2023-06-30 $605,008 178,469
2023-03-31 $854,864 178,469
2021-09-30 $114,282 86,578
2021-06-30 $656,261 86,578
2021-03-31 $495,176 74,800
2020-12-31 $394,670 61,000
2020-09-30 $264,075 50,300
2020-06-30 $360,988 52,166